Alex Bodenstab, MD
Adult Reconstructive Orthopaedic Surgery · Newark, DENPI 1104806025
Payments from drug & device makers
Across 43 payments — averaging $51.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$609
- Pacira Therapeutics, Inc.$348
- Zimmer Biomet$260
- Liberty Surgical Inc.$220
- Medacta USA, Inc.$146
- Arthrex$140
- plus $505 from 11 others
What the payments were for
- Food & beverage$2,228100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 12 | $609 |
| Pacira Therapeutics, Inc. | 7 | $348 |
| Zimmer Biomet | 4 | $260 |
| Liberty Surgical Inc. | 1 | $220 |
| Medacta USA, Inc. | 2 | $146 |
| Arthrex | 1 | $140 |
| Conformis, Inc. | 1 | $125 |
| Johnson & Johnson | 1 | $114 |
| Ferring Pharmaceuticals Inc. | 5 | $79 |
| Smith+Nephew | 1 | $40 |
| Maxx Orthopedics, Inc. | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Heraeus Medical, LLC. | 2 | $24 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| BD | 1 | $22 |
| KCI USA, Inc. | 1 | $14 |
| Synergy Orthopedics, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilretta$245
- NEW PRODUCT DEVELOPMENT$150
- TAPESTRY$135
- Identity Imprint CR$125
- Identity Imprint PS$125
- SIGMA$114
- EFFICIENCY$110
- TRIATHLON$102
How this compares
Too few adult reconstructive orthopaedic surgery providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $35,676 |
| Celecoxib | 28 | $457 |
| Amoxicillin | 103 | $257 |
| Mupirocin | 14 | $140 |
| Clindamycin Hcl | 15 | $138 |
| Methylprednisolone | 21 | $127 |
| Meloxicam | 13 | $115 |
| Gabapentin | 24 | $94 |
| Tramadol Hcl | 13 | $61 |
| Oxycodone Hcl | 14 | $59 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Newark
- Yehuda KerbelNewark$33K
- Craig SmuckerWilmington$4K
- David AxonWilmington$31
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.